Michael Evans

Dr. Michael Evans is a Professor in Residence at the University of California San Francisco (UCSF) in the Department of Radiology and Biomedical Imaging. A chemical biologist by training, he earned his PhD in Organic Chemistry from The Scripps Research Institute and completed postdoctoral work in Molecular Imaging at Memorial Sloan Kettering Cancer Center.

• Research Focus: Biomarker discovery, proteomics, nuclear medicine, theranostics, and molecular imaging of tumors.
• Clinical Translation: Principal Investigator on human trials for radiopharmaceuticals, co-founder of ORIC Pharmaceuticals, Therapaint, Honeybear Biosciences, and Hap10.

Key Publications: Over 80 peer-reviewed articles and 13 patents, emphasizing PET imaging, radioligand therapy, and iron metabolism in cancer. His work spans prostate, bladder, pancreatic, and breast cancers.

Scientific Recognition:

• 2024 Sam Gambhir Trailblazer Award
• 2023 Roger Tsien Award
• V Foundation Translational Science Grant (2020-2023)
• American Chemical Society Research Scholar Award (2017)

Professional Affiliations: American Chemical Society, Society of Nuclear Medicine and Molecular Imaging, World Molecular Imaging Society. Regularly invited to lecture nationally and internationally on nuclear medicine applications.